48 related articles for article (PubMed ID: 38560576)
1. Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma.
Liu J; Li W; Lu R; Xu J; Jiang C; Duan J; Zhang L; Wang G; Chen J
Oncol Res; 2024; 32(4):717-726. PubMed ID: 38560576
[TBL] [Abstract][Full Text] [Related]
2. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
Huang S; Dong C; Li D; Xu Y; Wu J
Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
[No Abstract] [Full Text] [Related]
3. The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.
Li W; Liu J
Front Immunol; 2022; 13():845585. PubMed ID: 35757728
[TBL] [Abstract][Full Text] [Related]
4. Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
Liu Y; Ma J; Wang X; Liu P; Cai C; Han Y; Zeng S; Feng Z; Shen H
Comput Biol Med; 2023 May; 158():106862. PubMed ID: 37044053
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression
Wang HQ; Qian CH; Guo ZY; Li PM; Qiu ZJ
World J Gastroenterol; 2022 Sep; 28(35):5141-5153. PubMed ID: 36188725
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NRAV enhances proliferation and invasion of hepatocellular carcinoma cells by modulating the Wnt/β-catenin signaling pathway.
Wang Q; Tang Y; Ge Y; Zhang S; Zheng M
Bioengineered; 2022 Apr; 13(4):10026-10037. PubMed ID: 35436415
[TBL] [Abstract][Full Text] [Related]
7. Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling.
Yin L; Zhou L; Gao S; Feng Y; Zhu H; Xiang J; Xu R
Front Mol Biosci; 2022; 9():807418. PubMed ID: 35187083
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
Front Oncol; 2021; 11():738477. PubMed ID: 34568075
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer.
Liu J; Zhang S; Dai W; Xie C; Li JC
Front Oncol; 2020; 10():586414. PubMed ID: 33520701
[TBL] [Abstract][Full Text] [Related]
10. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
Xu Q; Wang Y; Huang W
Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]